Skip to content

Author

Tom G. Caniels

We have 2 of 45 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Sequential vaccination matures VRC01-class HIV-1 neutralizing antibodies in humans

Inducing a broadly neutralizing antibody (bnAb) response is a key goal of HIV-1 vaccine development. Despite significant progress, it is unknown whether vaccine-primed B cells can be reactivated and matured to secrete bona fide bnAbs. In the IAVI C107/C110 single-arm, open-label human trial, VRC01-class memory B cells...

T. Caniels, Madhu S. Prabhakaran, S. Agrawal et al. · 0 citations
Review Open access Aug 2026

Preclinical and clinical trials for vaccine induction of CD4-binding site-neutralizing antibodies.

Progress toward a protective CD4bs-directed HIV-1 vaccine will require further optimization of adjuvants, delivery systems, and sequential immunogen design to balance precursor recruitment with structural constraint and to sustain affinity maturation across multidose regimens.

Catarina Mendes Silva, R. Sanders, Tom G. Caniels · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.